Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

MAXHEALTH's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.

Financial Ratios:

currentRatio 0.889000
forwardPE 40.818466
debtToEquity 32.367000
earningsGrowth 0.073000
revenueGrowth 0.122000
grossMargins 0.624150
operatingMargins 0.225590
trailingEps 14.710000
forwardEps 24.338250

MAXHEALTH's positive gross and operating margins indicate strong financial performance. These margins show that the company is profitable and efficient in its operations, with effective cost control contributing to its overall financial success.
Max Healthcare Institute Limited's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting Max Healthcare Institute Limited to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

MAXHEALTH's stock price has repeatedly hovered near the lower end of projections. This trend indicates that the company may be facing obstacles in achieving the growth anticipated by analysts.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


MAXHEALTH has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as MAXHEALTH is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.